Skip to content
HowShorted

ADIAL PHARMACEUTICALS, INC. short interest in 2026

In 2026, ADIAL PHARMACEUTICALS, INC.'s disclosed short interest ran from 1.21% of shares outstanding on 15 Jan 2026 to 8.00% on 15 Sep 2026, a change of +6.79 percentage points. The year's high was 9.32% on 31 Aug 2026 and its low 1.14% on 30 Jan 2026, averaging 4.88% across 11 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.13 days on 15 Sep 2026. Full history: ADIAL PHARMACEUTICALS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for ADIAL PHARMACEUTICALS, INC. in 2026

2026 in figures

Start of year
1.21% (15 Jan 2026)
End of year
8.00% (15 Sep 2026)
Change
+6.79 pp
High
9.32% (31 Aug 2026)
Low
1.14% (30 Jan 2026)
Average
4.88%
Highest days to cover
4.13 (15 Sep 2026)
SEC filings marked
6

Every report in 2026

ADIAL PHARMACEUTICALS, INC. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 20261.21%1.00
30 Jan 20261.14%1.00
13 Mar 20265.57%1.0010-K filed, results (8-K)
31 Mar 20266.78%1.31
15 Apr 20263.43%1.00
30 Apr 20264.80%1.00
15 May 20262.38%1.0010-Q filed, results (8-K)
29 May 20262.21%1.00
14 Aug 20268.82%2.7210-Q filed
31 Aug 20269.32%3.08results (8-K)
15 Sep 20268.00%4.13

See also: ADIAL PHARMACEUTICALS, INC.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.